Adjuvant therapy with nivolumab combined with ipilimumab vs nivolumab alone in patients with resected stage IIIB-D/IV melanoma
Adjuvant therapy with nivolumab combined with ipilimumab vs nivolumab alone in patients with resected stage IIIB-D/IV melanoma
Assessing comprehensive score for financial toxicity (COST) among radiation oncology patients in India
Autologous tumour infiltrating lymphocytes cell therapy in metastatic non-small cell lung cancer
Highlights from AORTIC Cancer Genomics Conference 2021
The Conquering Cancer Campaign
Durvalumab following radiotherapy in patients with unresectable, stage 3 NSCLC ineligible for chemotherapy
ecancer special issue on medical education in Africa
Cancer Genomics in Africa today
OncoAlert and ecancer weekly roundup for March 01 - 06, 2021
UICC Breast Cancer Programme: update and opportunities
Changes in cancer patient management in India during the pandemic
ERAS in gynaecological oncology from developed to developing countries